Research in the mechanism of ischemic cell death of cardiomyocyte and the role of mitochondria

心肌细胞缺血性细胞死亡机制及线粒体作用的研究

基本信息

  • 批准号:
    13670716
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2002
  • 项目状态:
    已结题

项目摘要

In the rat ischemia-reperfusion model, the effect of ischemic preconditioning, mitochondrial K-ATP channel openers, nicorandil and diazoxide, on the reduction of infarct size was tested. All these interventions reduced the infarct size significantly, indicating the importance of the opening of mitochondrial K-ATP cahnnels for the reduction of ischemic injury. The left ventricular remodeling was assessed by the LV pressure-volume relation at 3 weeks after infarction. The LV remodeling was attenuated by the opening of mitochondrial K-ATP channels and the extent of remodeling and infarct size was correlated. The mechanism of opening the mitochondrial K-ATP channels is distinct between nicorandil and diazoxide, since the effect of nicorandil was partially inhibited by PKC inhibitor, although the effect of diazoxide was not influenced. The PKC isoform translocation from cytosolic to mitochondrial fraction was assessed by Western blotting. This revealed that the PKC ε and δ was translocated to mitochondrial fraction by nicorandil, which is inhibited by PKC inhibitor. Furthermore, NO quencher reduced the translocation of these isoforms to the mitochondrial fraction indicates that the NO donor effect of nicorandil activates the PKC ε and δ, which subsequently activates the mitochondrial K-ATP cahnnels synergistically with the direct opening effect of nicorandil. The adaptor protein in mitochondria which bind to PKC ε and δ were explored by immunoprecipitation and new adaptor proteins are detected, which may play an important role for the activation of mitochondrial K-ATP channels.
在大鼠缺血-再灌注模型中,检测缺血预处理、线粒体K-ATP通道开放剂尼可地尔和二氮嗪对减少梗死面积的影响。所有这些干预措施均显著缩小了梗死面积,表明线粒体K-ATP通道开放对于减轻缺血性损伤的重要性。梗死后3周采用左室压力-容积关系评价左室重构。线粒体K-ATP通道开放可减轻左室重构,重构程度与梗死面积相关。尼可地尔和二氮嗪开放线粒体K-ATP通道的机制不同,因为尼可地尔的作用被PKC抑制剂部分抑制,但二氮嗪的作用不受影响。蛋白质印迹法检测PKC亚型从胞浆向线粒体的转移。这表明尼可地尔将PKC ε和δ易位至线粒体组分,这可被PKC抑制剂抑制。此外,NO猝灭剂减少了这些亚型向线粒体组分的易位,表明尼可地尔的NO供体效应激活PKC ε和δ,随后与尼可地尔的直接开放效应协同激活线粒体K-ATP通道。通过免疫共沉淀法检测了线粒体中与PKC ε和δ结合的接头蛋白,发现了新的接头蛋白,它们可能在线粒体K-ATP通道的激活中起重要作用。

项目成果

期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Masayasu Kimura, Yoichi Mizukami, Toshiro Miura, et al.: "Orphan G protein-coupled receptor, GPR41, induces apoptosis via a p53/Bax pathway during ischemic hypoxia and reoxygenation"J. Biol. Chem.. 276. 26453-26460 (2001)
Masayasu Kimura、Yoichi Mizukami、Toshiro Miura 等人:“孤儿 G 蛋白偶联受体 GPR41 在缺血性缺氧和复氧过程中通过 p53/Bax 途径诱导细胞凋亡”J.
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Mitsuo Iwatate, Toshiro Miura, Yasuhiro Ikeda, et al.: "Effects of in vivo gene transfer of fibroblast growth factor-2 on cardiac function and collateral vessel formation in microembolized rabbit heart"Jpn. Circ. J.. 65. 226-231 (2001)
Mitsuo Iwatate、Toshiro Miura、Yasuhiro Ikeda 等:“成纤维细胞生长因子-2 体内基因转移对微栓塞兔心脏心脏功能和侧支血管形成的影响”Jpn。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Toshiro Miura: "Molecular biology of the heart"Medical View. 1-242 (2001)
三浦敏郎:《心脏的分子生物学》医学观点。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Mitsuo Iwatate: "Effects of in vivo gene transfer of fibroblast growth factor-2 on cardiac function and collateral vessel formation in microembolized rabbit heart"Jpn Circ J. 65. 226-231 (2001)
Mitsuo Iwatate:“成纤维细胞生长因子-2的体内基因转移对微栓塞兔心脏的心脏功能和侧支血管形成的影响”Jpn Circ J. 65. 226-231 (2001)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
三浦俊郎: "心臓における生命現象の分子生物学"メディカルビュー社. 242 (2001)
三浦敏郎:“心脏生命现象的分子生物学”医学观点出版242(2001)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IKEDA Yasuhiro其他文献

IKEDA Yasuhiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IKEDA Yasuhiro', 18)}}的其他基金

The relation between chronic inflammatory reaction and photoreceptor cell death in retinitis pigmentosa
色素性视网膜炎慢性炎症反应与感光细胞死亡的关系
  • 批准号:
    24659763
  • 财政年份:
    2012
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Incentive Design In Lawyer Social Role over Legal Access
律师社会角色对法律准入的激励设计
  • 批准号:
    22530012
  • 财政年份:
    2010
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of novel therapeutic strategy for heart failure which targets aberrant phosphorylation status in the sarcoplasmic reticulum of failing hearts
开发新的心力衰竭治疗策略,针对衰竭心脏肌浆网的异常磷酸化状态
  • 批准号:
    21590932
  • 财政年份:
    2009
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of the molecular mechanism for human pigment epithelium-derived factor (hPEDF) mediated photoreceptor cell neuroprotection
人色素上皮衍生因子(hPEDF)介导感光细胞神经保护的分子机制分析
  • 批准号:
    20791259
  • 财政年份:
    2008
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Exploration of abnormal dephosphorylation mechanism via Protein phosphatase 1β in heart failure
心力衰竭中蛋白磷酸酶1β异常去磷酸化机制的探讨
  • 批准号:
    17590739
  • 财政年份:
    2005
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Normalization of increased protein phosphatase 1 activity by using an high efficiency myocardial gene transfer technique in chronic heart failure
在慢性心力衰竭中使用高效心肌基因转移技术使增加的蛋白磷酸酶 1 活性正常化
  • 批准号:
    15590754
  • 财政年份:
    2003
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Neuroendcrine study of the affect stress that it originates in the masticatory function
源于咀嚼功能的情感应激的神经内分泌研究
  • 批准号:
    14370642
  • 财政年份:
    2002
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Nck1 in Ischemia Reperfusion Injury
Nck1在缺血再灌注损伤中的作用
  • 批准号:
    10715406
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Mitochondria-mediated mechanisms of ferroptosis in response to cardiac ischemia-reperfusion injury
线粒体介导的铁死亡响应心脏缺血再灌注损伤的机制
  • 批准号:
    10681495
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Role of microRNA-98 in Myocardial Ischemia Reperfusion Injury in Late Pregnancy
microRNA-98在妊娠晚期心肌缺血再灌注损伤中的作用
  • 批准号:
    10606041
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Change in NSF ATPase activity Leads to Brain Ischemia Reperfusion Injury
NSF ATP酶活性变化导致脑缺血再灌注损伤
  • 批准号:
    10748602
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Mitochondria-mediated mechanisms of ferroptosis in response to cardiac ischemia-reperfusion injury
线粒体介导的铁死亡响应心脏缺血再灌注损伤的机制
  • 批准号:
    10409003
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Role of the mitochondrial LonP1 in myocardial ischemia and reperfusion injury protection
线粒体LonP1在心肌缺血再灌注损伤保护中的作用
  • 批准号:
    10446477
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Novel anti-NPC aggregation strategy against brain ischemia-reperfusion injury
抗脑缺血再灌注损伤的新型抗NPC聚集策略
  • 批准号:
    10747258
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Role of the mitochondrial LonP1 in myocardial ischemia and reperfusion injury protection
线粒体LonP1在心肌缺血再灌注损伤保护中的作用
  • 批准号:
    10640920
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Mitochondrial regulation of the NLRP3 inflammasome in myocardial ischemia-reperfusion injury and heart transplantation
NLRP3炎症小体在心肌缺血再灌注损伤和心脏移植中的线粒体调控
  • 批准号:
    10306406
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
Mitochondrial regulation of the NLRP3 inflammasome in myocardial ischemia-reperfusion injury and heart transplantation
NLRP3炎症小体在心肌缺血再灌注损伤和心脏移植中的线粒体调控
  • 批准号:
    10133482
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了